A decision to reclassify marijuana as a Schedule III drug would completely change how the industry pays for it, how we think of weed, and what we can learn about it. The U.S Drug Enforcement ...
The US Food and Drug Administration (FDA) has issued an urgent nationwide recall of more than 140,000 bottles of Atorvastatin ...
The U.S Drug Enforcement Administration is moving to reclassify marijuana as a less harmful drug in the eyes of the federal government. Cannabis is currently considered a dangerous Schedule I drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback